Hexagon Nutrition Limited operates as a nutraceutical business focused on the development and supply of micronutrient premixes, clinical nutrition, and therapeutic food in India and South Africa, Malaysia, Ethiopia, France, French Polynesia, Ghana, Indonesia, Kenya, Madagascar, Mozambique, Papua New Guinea, Nigeria, Philippines, Qatar, UAE, Mauritius, Brazil, Bangladesh, Rwanda, and Internationally. The company provides ready-to-use supplementary food (RUSF), ready-to-use therapeutic food (RUTF), health and wellness products, and home fortification solutions. It also develops functional foods, dietary supplements, plant-based nutritional alternatives, maternal and geriatric nutrition products, and condition-specific formulations aimed at managing lifestyle disorders, such as diabetes, cardiovascular health, and obesity. It serves food companies and nutraceutical industry. The company was founded in 1991 and is headquartered in Mumbai, India.
| Current Price | ₹61.00 |
|---|---|
| Market Cap | ₹899 Cr |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Vitamins and Nutritional Supplements |
| P/E Ratio | 22.2 |
| Return on Equity | 16.26% |
| 52-Week Range | ₹48.10 – ₹78.25 |
| Beta (1Y) | -0.05 |
| Dividend Yield | 0.44% |
| Revenue | ₹104 Cr |
|---|---|
| Net Profit | ₹8 Cr |
| EPS (Basic) | ₹0.67 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
1. Nutraceuticals-100%
Hexagon Nutrition Limited is trading at ₹61.00, with a market capitalisation of ₹899 Cr.
Hexagon Nutrition Limited operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Vitamins and Nutritional Supplements).
Hexagon Nutrition Limited has a P/E of 22.2 and a return on equity of 16.26%.
In Q1 FY27, Hexagon Nutrition Limited reported revenue of ₹104 Cr and net profit of ₹8 Cr, with basic EPS of ₹0.67 (consolidated, parsed from the company's exchange filing).